Home > Drugs A – Z > Potassium Phosphate (By injection)

Potassium Phosphate (By injection)

Treats or prevents low levels of phosphorus in the blood.

What works?

Learn more about the effects of these drugs. The most reliable research is summed up for you in our featured article.

Potassium phosphate injection is a phosphate supplement that is used to treat or prevent hypophosphatemia (low phosphorus in the blood). It is also used as an additive in the preparation of fluid formula injections. This medicine is to be given only by or under the direct supervision of a doctor… Read more
Drug classes About this
Parenteral Electrolyte, Potassium
Combinations including this drug

What works? Research summarized

Evidence reviews

Octaplas Compared with Fresh Frozen Plasma to Reduce the Risk of Transmitting Lipid-Enveloped Viruses: An Economic Analysis and Budget Impact Analysis [Internet]

Health Canada recently licensed Octaplas, which can now be considered as an alternative to standard fresh frozen plasma (FFP) for certain indications. Since, on average, 200,000 units of FFP are transfused annually in Canada, the widespread implementation of Octaplas may have significant public health and economic implications. This study investigates the cost-effectiveness position of Octaplas against standard FFP and its budgetary impact to the health care system.

Mobile Applications and Internet-based Approaches for Supporting Non-professional Caregivers: A Systematic Review [Internet]

Non-professional caregivers are an important source of physical, emotional and other support to ill or injured Veterans. With an increasing number of Veterans who require care and assistance for traumatic brain injuries (TBI), physical impairments, or other debilitating disorders such as post-traumatic stress (PTSD) and dementia, there is a greater growing demand for spouses, parents or other family members and friends to assume the role of caregiver. Electronic health applications and tools are increasingly available and have the potential to facilitate caregiving outside of traditional healthcare settings, especially in the context of the rising use of smartphones and mobile technologies. Lessons learned from prior consumer health information technology (CHIT) interventions could help inform the development of health-related mobile applications. CHIT applications are defined as electronic tools or technologies intended for use by consumers, by patients or family members, that interact directly with users for the management of their health or healthcare, and in which data, information, or other recommendations are tailored and/or individualized; the system may or may not link to a health professional or health system services. The Veterans Health Administration (VA) is currently developing mobile applications intended for use by seriously injured post-9/11 Veterans and their family caregivers enrolled in the Comprehensive Assistance for Family Caregivers program. This report was requested on behalf of the VA offices that are developing these mobile tools. The objectives of this report are the following: 1) to identify studies of CHIT applications that aim to support the needs of caregivers; 2) examine the usage and effects of CHIT applications on caregiver burden outcomes, and patient outcomes, clinical process measures, and healthcare utilization of interest; 3) discuss parallels that can be drawn from pediatric literature, and 4) identify gaps in the literature.

Non-pharmacological treatments for stuttering in children and adults: a systematic review and evaluation of clinical effectiveness, and exploration of barriers to successful outcomes

The study found that although much of the evidence identified was from studies at risk of bias, most available interventions for stuttering may be of benefit to at least some people who stutter. There is a requirement for greater clarity regarding what the core outcomes following stuttering intervention should be and also enhanced understanding of the process whereby interventions effect change.

See all (12)

Summaries for consumers

Pharmacological interventions for preventing complications in idiopathic hypercalciuria

Idiopathic hypercalciuria is an inherited metabolic abnormality characterised by excessive amounts of calcium excreted into the urine in patients with normal serum levels of calcium. The main complications of this disease in adults are the formation of kidney stones and bone loss. In children, hypercalciuria can cause recurrent haematuria (blood in the urine), frequency‐dysuria syndrome (frequent painful or difficult urination), urinary tract infection and abdominal and back pain. The aim of this review was to evaluate the benefits and harms of drug treatments for preventing the complications of idiopathic hypercalciuria. We identified four studies comparing thiazides (diuretics) with either standard treatment of clinical follow‐up and increased water intake or specific dietary recommendations and one study comparing thiazides plus a potassium salt. There was a decrease in the number of new stones in the group receiving thiazides as well as an increase in the time taken for new stone formation. The addition of potassium salts to thiazide treatment significantly reduced the amount of calcium excreted in the urine. No studies in children were identified and there were no studies investigating the use of drug treatment for those with hypercalciuria but were symptom free.

PubMed Health Blog...

read all...